Study: Elemental Analysis Market Trends 2016

Elemental analysis is a process of detection and quantification of elemental compounds, molecular species and elements. This analysis technique is a part of analytical chemistry and can be qualitative and quantitative in nature. Sample types tested for trace elements comprises of aqueous, non-aqueous, organic and non-organic materials. For organic chemists, elemental analysis refers to CHNX analysis, which is used to determine the purity and structure of a compound. In this technique, a sample is burnt in excess of oxygen and thereby collecting combustion products like carbon dioxide, nitric acid and water. The masses of these products are used to determine composition of the sample. Ultra trace analysis and elemental trace analysis detection range from parts per million (ppm), to parts per billion (ppb) and parts per trillion (ppt) levels, using updated techniques and instruments. Some of the major technologies used for elemental analysis include inductively coupled plasma mass spectrometry, inductively coupled plasma optical emission spectrometry, X-ray Fluorescence and X-ray Diffraction among others.  

Some of the key driving factors for elemental analysis market are increasing concern for food safety, increasing usage of X-ray fluorescence in clinical research and growing R&D funding in life sciences. Moreover, this technology has a wide range of application areas in different segments of industry and thus has a major market worldwide. There are other geographical drivers which are also responsible for the growth of the market. In addition, demand from emerging markets across India and China are expected to create opportunities for elemental analysis market in the future. However, high cost of elemental analyzers and urge for efficient professionals act as major restraints to the growth of the market. 

Global elemental analysis market can be broadly classified on the basis of types, technology, applications and geography. By types, the market for elemental analysis is segmented into organic and inorganic. The market is divided by technology into destructive and non-destructive technologies. Moreover, elemental analysis has different application areas including food and beverage testing, life sciences, environment testing and geology among others.  

Request a Sample Study: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5144

Currently North America is dominating the market for elemental analysis in terms of revenue, followed by Europe and Asia-Pacific. The major factor responsible for immense development of elemental analysis market in North America is rapid technological advancement of this technique in various application areas, such as food and beverage, biotechnology, chemical and semiconductor industries among others. However, Asia Pacific is anticipated to grow at a significant rate in the future, primarily due to increasing awareness for elemental analysis in China and India coupled with rising demand from applied markets. Furthermore, strategic expansion by manufacturers in China and use of modern analysis technique in Chinese medicines are likely to develop the market for elemental analysis in Asia Pacific.

Some of the key players in this market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), AMETEK, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Elementar Group (Germany) and Rigaku Corporation (Japan) among others.

Rise in Cardiovascular Diseases Driving Global Medical Laser Systems Market at 12.50% CAGR

The global medical laser systems market is dominated by North America. This regional market for medical laser systems is driven by the increasing prevalence of chronic disorders such as diabetes and obesity. Europe is another key regional market in the global medical laser systems market. On the other hand, it is Asia Pacific that is the most attractive region in the global medical laser systems market. This regional market offers the maximum opportunities for future growth.

The key factors driving the Asia Pacific medical laser systems market are the increasing disposable income and the high level of unmet medical needs in populous nations such as China and India. Broadly, the global medical laser systems market is segmented on the basis of product, application, and geography.

Besides offering a detailed analysis of the key regions, the study also offers an in-depth analysis of the key application and product segments. The leading segments of the global medical laser systems market and the fastest growing segments have also been evaluated in the report. The key trends driving these segments are also included. Moreover, the valuable forecasts of these segments are also covered.

Overview of the Global Medical Laser Systems Market 

The global medical laser systems market is projected to expand at a 12.50% CAGR during the forecast period from 2012 to 2018. In 2011, the global medical laser systems market was worth US$0.9 bn and by 2018, the market is projected to be worth US$2.0 bn. The market is driven by the elevated rate of age-related ophthalmic disorders and the rising awareness related to medical aesthetics.

By product, the global medical laser systems market is segmented into diode laser systems, gas laser systems, solid state laser systems, and dye laser systems. The diode laser systems segment dominated the global medical laser systems market in 2011. Application-wise, the global medical laser systems market is divided into cardiovascular, dentistry, urology, gynecology, ophthalmology, dermatology, and others. By 2018, the cardiovascular segment is expected to emerge as the most rapidly developing application. The cardiovascular segment is driven by the development of affordable treatment methods and the rising prevalence of cardiovascular diseases.

Get a Custom Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=324

Regionally, the global medical laser systems market is classified into Asia Pacific, Europe, North America, and Rest of the World (RoW). In 2011, the global medical laser systems market was led by North America, followed by Europe. In 2011, North America held a dominant share of 35% in the global medical laser systems market.

Although the global medical laser systems market will expand notably in the coming few years, it will be suppressed by several factors. These include the high failure rates associated with medical laser systems, the implementation of the Affordable Care Act in the U.S., and stringent safety regulations in this market.

Companies mentioned in the research report 

Players in the global medical laser systems market will benefit from the increasing level of disposable incomes in emerging economies. Some of the key players operating in the global medical laser systems market are PhotoMedex, Lumenis, Syneron Candela, AngioDynamics, BIOLASE, and American Medical Systems, Spectranetics Corporation.

Platelet Aggregation Devices Market to Gain from New Applications in Diagnostics

Platelet Aggregation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023,’ a new report by Transparency Market Research, offers actionable insight into the market’s dynamics. Platelet aggregation is a condition that occurs in the chain of events leading up to the formation of a blood clot. Platelet aggregation can be studied through specific tests. This test is commonly conducted before a surgery, to diagnose any dysfunction in the platelet, and so on. 

The growing incidence of diseases such as dengue and malaria in Asia and a higher number of people

undergoing surgeries across the world will likely fuel the global platelet aggregation devices market till 2023.

To conduct a meticulous study of the global platelet aggregation devices market, the report segments the market based on device type, end users, and geography. 

Get Sample Research Papers on Platelet Aggregation Devices Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6541

By device type, the market has been segmented into: platelet function analyzer (PFA), platelet function centrifuge, aggregometers, consumables and accessories, and platelet collection systems. Of these, PFA has been identified as the most widely used platelet aggregation device given its critical task of aspirating in-virto blood collected as a sample into the cartridge test. The PFA helps diagnosticians study platelet function and count besides other specific elements.

Furthermore, studying the market on the basis of end users, the report segments the global platelet aggregation devices market into diagnostic laboratories, hospitals, CROs and medical research institutes, and other end users. 

To study the most attractive regional markets, the report divides the global platelet aggregation devices market into the following geographical segments: North America (U.S and Canada), Europe, Asia Pacific, and Rest of the World. The United States and Canada dominate the global platelet aggregation devices market and are trailed by Europe in the second position globally. The leading position of these regions can be ascribed to the presence of leading players seated in the developed countries in North America and Europe. 

The opportunities, however, are gradually moving eastward with the remarkable growth of countries in the Asia Pacific region. Mosquito-borne diseases such as malaria and dengue are on the rise in countries such as India, where the demand for platelet aggregation devices will continue to show an uptick.

Worldwide, the demand for platelet rich aggregation devices doesn’t just stem from screening programs for epidemics such as dengue and HIV. The market can also expect to see new opportunities among patients undergoing anti-platelet therapy. 

The ability to present a clear result with the use of a minimal blood sample is a feature users look for in platelet aggregation devices. However, purchase decisions could be restrained by the high cost and limited usage of such devices. Companies that rake in an appreciable portion of revenue in the global platelet rich aggregation devices market are: Bio Data Corporation, Haemonetics Corporation, Drucker Diagnostics, F. Hoffmann-La Roche Ltd., Helena Laboratories, Siemens Healthcare, Laboratory Corporation of America Holdings (LabCorp), and Sienco.

In-vitro Colorectal Cancer Screening Tests Industry to Boost in Upcoming Years!

Colorectal cancer, also known as bowel cancer, colorectal adenocarcinoma, or colon cancer, is a type of cancer that results from uncontrolled growth of the cells of rectum or colon. Factors such as growing geriatric population, rising prevalence of colorectal cancer, technological advancement, introduction of non-invasive screening tests are driving the growth of the global in-vitro colorectal cancer screening tests market. This report studies the current scenario as well as future market potential for in-vitro colorectal cancer screening tests globally. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

Increase in the geriatric population, rise in prevalence of colorectal cancer, high prevalence of inflammatory bowel disease, and easy access to health care facilities contribute to the growth of the in-vitro colorectal cancer screening tests market. Geographically, the in-vitro colorectal cancer screening tests market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World. North America accounted for the largest share of the in-vitro colorectal cancer screening tests market in 2014, followed by Europe.

You can avail a sample at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3698

In terms of revenue, North America was the largest market for in-vitro colorectal cancer screening tests, and accounted for a share of over 35.0% of the global market in 2014. Dominance of North America has been attributed to rise in health awareness among the population, the scope of expansion of clinical laboratories, rapid introduction of advanced technological implementations, and increase in incidence of colorectal cancer. Additionally, rise in geriatric population and availability of various reimbursement policies from public and private health insurance firms fuel the growth of the in-vitro colorectal cancer screening tests market in North America. The U.S. dominated the in-vitro colorectal cancer screening tests market in North America. Positive initiatives by the U.S. Government are anticipated to boost market growth during the forecast period.

Europe was the second largest market for in-vitro colorectal cancer screening tests in 2014. Major countries in Europe such as the U.K., Germany, France, Russia, Spain, Italy, Switzerland, the Netherlands, Portugal, and Belgium accounted for a majority share of the in-vitro colorectal cancer screening tests market in Europe in 2014. Key factors driving the growth of the market in Europe are rising demand for technologically advanced products, easy adoption of screening tests, increasing geriatric population, and growing health care awareness. Germany is considered to be a promising market for in-vitro colorectal cancer screening tests due to increase in acceptance of technologically advanced products, rise in geriatric population, growth in incidence of colorectal cancer, and cost-effective screening tests.

Asia Pacific was the third largest market for in-vitro colorectal cancer screening tests in terms of revenue in 2014. However, the market in the region is expected to expand at a CAGR of 18.6% during the forecast period from 2015 to 2023. Factors attributed to the rapid growth of the in-vitro colorectal cancer screening tests market in Asia Pacific are constant rise in the geriatric population, increase in the prevalence of colorectal cancer and inherited syndrome, and surge in health care expenditure. Rest of Asia Pacific dominated the in-vitro colorectal cancer screening tests market in Asia Pacific due to developing health care infrastructure and rise in awareness related to colorectal cancer. Rest of Asia Pacific comprises South Korea, Malaysia, Singapore, Indonesia, Thailand, Vietnam, Taiwan, and the Philippines, among other countries. The in-vitro colorectal cancer screening tests market in Latin America and Rest of the World is expected to expand at moderate growth rate during the forecast period due to the gradually improving financial stability, high prevalence of colorectal cancer, and introduction of non-invasive screening tests in the region.

Cell Expansion - A Big Move in Cancer Treatment!

Cell expansion is defined as the production of daughter cells which arise originally from the single cell. Cell expansion is beneficial either therapeutically as drug screening tools or for core research purposes. Currently, cell expansion is majorly used for stem cells expansion which are transplanted in patients with blood cancer. Cell expansion also has a potential to be used in various diseases linked with genetic defects such as Parkinson’s diseases or Alzheimer’s disease. The cell expansion market can be differentiated into various segments on the basis of type of cells used for expansion and by applications. On the basis of type of cells used for expansion, the cell expansion market has been differentiated into three classes which include:

• Human Cells

• Animal Cells

• Plant Cells

Human cells capture the major share of the cell expansion market on the basis of cell type. These

cells are used for therapeutic applications for curing various types of cancers and genetic disorders. Human cells market could further be segmented into two classes which include stem cells and differentiated cells. Animal cell expansion on other hand is used for very less therapeutic applications however; plant cell expansion is currently under research activities for therapeutic applications. On the basis of applications, the cell expansion market has been classified as follows:

• Stem cell research

• Regenerative drugs

• Biotechnology and biopharmaceuticals

• Clinical diagnostics

Stem cell research dominates the cell expansion factors. Extensive use of stem cells for therapeutic cancer and genetic diseases involves the extensive cell expansion procedure. Biotechnology and biopharmaceutical research also involves the cell expansion to a high extent. Recently, GE Healthcare has launched a cell expansion technology, Xuri W25 that is designed to develop T-cell and is used for performing T-cell therapies. Cell expansion based cellular regenerative medicines are used majorly for developing medicines for cardiovascular and neurological diseases.

Get a Sample Copy of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9037

Bone Graft and Substitutes Market: Growing Demand for Bone Graft Substitutes to Expand Market at 4.5% CAGR

A recent research report published by Transparency Market Research projects the global bone graft and substitutes market to expand at a CAGR of 4.5% during the period between 2015 and 2023. The report, titled “Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023”, estimates the global market for bone graft and substitutes to be worth US$3.48 bn by 2023. The overall market stood at a valuation of US$2.35 bn in 2014.

The report points out that the growing prevalence of bone and joint disorders, along with the rise in number of orthopedic surgeries will drive the demand from the global bone graft and substitutes market. Rapidly growing medical tourism across developing countries will also boost the growth of the overall market. However, the risks of post implantation infections and ethical issues are expected to restrain the market during the forecast horizon. The global bone graft and substitutes market has a huge opportunity to grow across emerging economies with the availability of large patient pool and rise in disposable income.

On the basis of types, the report segments the global bone grafts and substitutes market into allograft and bone graft substitutes. Allograft refers to a tissue graft received from a donor of the same species. Ready availability of allografts in various sizes and shapes is expected to fuel the demand for allograft during the forecast horizon. Around one-third of the bone graft procedures across the U.S. use allografts. To reduce the risks of infections, allograft tissue undergoes sterilization, freeze drying, and tissue freezing. The allograft segment is projected to expand at a CAGR of 3.9% during the forecast period and reach a valuation of US$1,148.0 mn by 2023.

Get a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6200

Bone graft substitutes segment is estimated to register the fastest growth in the global bone graft and substitutes market during the period between 2015 and 2023. Bone graft substitutes segment is further divided into bone morphogenetic proteins (BMPs), synthetic bone grafts, and others. In 2014, the demand for bone morphogenetic proteins was the highest and the sub-segment accounted for 34% share in the bone graft substitutes market in 2014.

In terms of applications, the report categorizes the global bone graft and substitutes market into long bone, spinal fusion, craniomaxilofacial, foot and ankle, joint reconstruction, and dental. While allografts are widely used for spinal trauma, craniomaxilofacial, joint reconstruction, and dental procedures, synthetic bone grafts are used spinal fusion and long bone procedures. In 2014, the spinal fusion application segment dominated the overall market owing to increasing demand for minimally invasive surgeries.

The report studies the global bone graft and substitutes market across Latin America, Asia Pacific, Europe, North America, and Rest of the World. The market is projected to expand across the emerging economies in Asia Pacific, Latin America, and Rest of the World.

The report profiles some of the key players in the global bone graft and substitutes market such as Medtronic plc, AlloSource, Stryker Corporation, DePuy Synthes, Baxter International, Nuvasive Inc., Wright Medical Group, Zimmer Inc., and Orthofix Holdings Inc. 

Promising Research and Favorable Legislation Spurring Growth in Disposable Medical Sensors Market

The medical devices manufacturing companies are in a nonstop process of improving medical devices in terms of convenience, safety and most prominently, sterility. This sterility factor significantly led to the manufacturing of the disposable medical devices. The new sensor technology that senses as well as records changes in any electrical properties aided the creation of disposable medical sensors. The use of these sensors in medical sector strongly depends on the type of application. The various types of disposable medical sensors includes ingestible sensor, implantable sensors, and invasive sensors.An ingestible digital sensor is swallowed in a pill for tracking health data from inside the human body. Implantable sensors are mainly used in medical research for measuring force, temperature, and pressure inside the human body.Invasive sensors are used for detection of physical as well as chemical parameters by inserting a probe inside a human body. 

In medical diagnostics, sensors are necessary in digital thermometers, digital blood pressure meters, breath analyzers, peak flow meters, spirometers, sleep apnea monitoring devices and respiration pulse oximeters. The therapeutic equipment such asheart-lung machines, respiration equipment and anesthetic equipment in intensive care, as well as infusion and transfusion pumps use these disposable sensors. Therapeutic sleep apnea devices and dialysis systems are the further examples of therapeutic equipment which in turn rises the sensors demand. 

Get a Sample Copy: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7679

On the basis of technologies, the disposable medical sensors are categorized into temperature, pressure, image, acoustic, gas, and flow sensors. Disposable blood pressure sensors are used for continuous patient’s blood pressure monitoring during the surgery.They are plugged in to a monitor which then shows the patients’ vital information. Pressure sensors are also used in intensive-care units (ICU), however must be replaced in every 24 hours. The image sensors along with camerascan be used for optical, X-ray and ultrasonic purposes in hospitals and clinics.

The global demand of wireless wearable,and disposable medical sensors continues to increase in a significant manner. In May 2012, the Federal Communications Commission (FCC)eliminated the protected broadband spectrum in the wireless medical sensor devices called medical body area networks (MBANs). These sensors monitor as well as read vital signs of a patient wirelessly. This decision was taken at the suggestion of Philips Healthcare, and GE Healthcare. FCC has also allocated 40 MHz of spectrum for MBAN devices to use on a shared and secondary basis. 

The growing demand for sensors in clinics and in homes for treatment or diagnosis purpose is the major factor that is driving the global disposable medical sensors market. The increasing prevalence of chronic long term diseases such as cancer andkidney disorders along with rising incidences of infections in hospitals are propelling the need for global disposable medical sensors in medical sector. Also, thegrowing number of patients worldwide has significantly increased the adoption of disposable medical sensors among end-users. In addition, the rising government provisions, huge investments in healthcare sector and technological developmentssuch as wearable wrist watch devices as well asdisease detectiondevices are further expected to fuel the growth of global disposable medical sensors market.

Companies in disposable medical sensors market are coming up with various product launches along with innovations in order to tailor with rising and varying demand among end-users. For instance, in July 2015, MEMSIC, Inc. launched MFC2030 Bi-Directional Flow Sensor for medical applications such as anesthesia, analytical instruments, and process control. In October 2014, Sensirion AG launched disposable liquid flow sensors for medical devices. They are intelligent, compact as well as cost-effective disposable flow sensors. These sensors provide liquid flow measurement capability inside a medical tubing, such as catheter or infusion set on a real time basis. 

Some of the key players in disposable medical sensors market are Sensirion AG, MEMSIC, Inc., Measurement Specialties, ST Microelectronics, Smiths Medical, Philips Healthcare, Freescale Semiconductor, Inc., Medtronic, GE Healthcare, Analog Devices, Inc., Honeywell International, Inc. Given Imaging Ltd., and Coividien, plc.

Healthcare Industry to Grow due to Cutting-Edge Technologies Being Introduced By IT and Telecom Sectors

A new market research report by Transparency Market Research, titled “The Role of IT and Telecom in Healthcare Industry Analysis and Forecast 2015-2023”, presents an extensive study on the key roles of telecom and IT within the healthcare industry. The growth trends seen in the healthcare industry owing to IT and telecom playing major roles have also been illustrated in this study. The numerous opportunities, drivers, and inhibitors experienced by the healthcare industry in the forecast horizon have also been presented in this report. The growth of the industry has been estimated on the basis of revenue across various geographical segments. The competitive profiling of the prime players operating in the telecom and IT sectors and the various technologies introduced by them for the development of the healthcare industry are also a part of this study. Thus, the report provides a closer look on the healthcare industry, particularly from the perspective of the telecom and IT industry. 

Add caption

As per the report, IT supports the healthcare industry by handling a number of peripheral and core operations of the industry. The functions of IT range from patient data storage to patient health monitoring to the presentation of optimal therapies for patients. Various cutting-edge technologies such as SaaS, telecom-centric solutions, and cloud computing have been specifically developed for the healthcare industry. The advent of telecom has also resulted in healthcare providers leveraging their conventional medical care resources such as clinics, hospitals, and equipment across a broader remote patient base. In addition, telecom providers have fulfilled the rising demand from the healthcare industry for greater bandwidth, mobility solutions, and high-performance technologies. 

Get a Sample Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=99

Moving further, the report states that the development in telecommunications has also enabled remote patient monitoring as well as accurate methodologies for the treatment and diagnosis of medical conditions. This is why the quality of medical care is predicted to immensely improve in emerging economies in the coming years. Further, the report states that 24/7 monitoring is made possible by the implementation of telecom and IT in the healthcare industry. This has resulted in an increasing demand for telecommunications and IT products within the healthcare industry and this demand is poised to increase in forthcoming years, as per this study.

The report states that owing to rising usage of interconnected networks as well as electronic health records (EHR), collaboration will be seen amongst care teams, clinicians, and organizations for optimization of treatment resources in the healthcare industry. In the last section of the report, the healthcare industry has been segmented on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World (RoW). Data regarding the performance of each regional segment is given in the report.

Factor Assays Market Opportunities and Trends 2020

Factor assays are mainly undertaken during prolongation of the Activated Partial Thromboplastin Time (APTT) and Partial Thromboplastin Time (PTT) resulting in the deficiency of one or more clotting proteins. Overall a basic general principle is followed by all functional clotting factor assays that involves specific plotting/clotting time from either PTT or APTT depending on which factor it’s being assayed against sample dilution. A quantitative assay of an individual clotting factor is essential to identify inherited deficiency and to monitor replacement therapy and sometimes helps to distinguish acquired defects e.g. disseminated intravascular coagulation (DIC), vitamin K deficiency, inhibitors.

In a decade, it has been forecasted that growing cost pressures in major industrialized nations and continuous technological advances would drastically change coagulation testing practice. While automated instruments market would supplement the growth of factor assay market with new sensitive and specific markers of homeostasis. Opportunities for application of factor assays will increase mainly into quality control of products and services due to technological development and standardization of its various methods. Decentralization of the factor assay testing would occur due to continuous contraction of hospital system and technical advances that will create additional opportunities and challenges for suppliers.

North America is the largest factor assay market globally followed by Europe as most of the diagnostic testing is supplemented with technological superiority, R&D investment and increase in acceptance for time efficient testing techniques. Asia-Pacific is the growing market because of periodic shift of R&D functions from companies based in the U.S and Western Europe.

Some of the key players of this market are Abbott, Werfen Group (Instrumentation Laboratory), Avocet Medical, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Helena Laboratories, HYPHEN BioMed, Hoffman-La Roche, Seimens AG, Trinity Biotech PLC and others.

IT-enabled Healthcare Market: Developing Economies Stealing the Spotlight

The IT-enabled healthcare segment of the overall healthcare industry is one of the most promising and rapidly expanding markets today. Research indicates that the IT-enabled healthcare market around the world will expand at an 11.80% CAGR from 2014 to 2020, rising from its valuation of US$96.8 bn in 2013 to US$210.3 bn by 2020. 

Even though developed regions such as North America and Europe – being the early adopters of

eHealth solutions – currently dominate the global IT-enabled healthcare market, the focus is fast shifting to developing economies in Asia Pacific, Latin America, and the Middle East, despite the late penetration of IT-enabled healthcare. These regions offer immense growth opportunities and are projected to witness remarkable expansion over the next few years 

Countries in Latin America Gaining Prominence 

The World Bank recently reported that universal healthcare in Latin America is on the rise, with countries such as Costa Rica, Colombia, Panama, Jamaica, Guatemala, Chile, Brazil, and Mexico witnessing a transformational growth in the healthcare sector. This boost indicates that Latin America has immense potential when it comes to IT-enabled healthcare. 

Get a Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3918

Earlier this month, International Living magazine listed Colombia, Panama, and Costa Rica among the top four countries with the best healthcare in the world. Factors such as high quality healthcare, affordable health coverage, state-of-the-art hospitals, presence of top-notch private healthcare providers, and growth of medical tourism drive the healthcare sector in this region, and these factors make Latin America an ideal destination for IT-enabled healthcare. 

With Promises Galore, India Attracts Several Market Players 

Like many other Asian countries, India too has been undergoing rapid technological changes in almost every industry and the healthcare sector is no exception. The IT-enabled healthcare market in India has been greatly impacted by the efforts of the government in the form of publishing of various e-health journals and formation of key organizations such as the Medical Informatics Society of India and the Telemedicine Society of India. IT-enabled healthcare is one of the successful ways by which India has been transforming its healthcare industry. One of the most prominent factors that works in the favor of the IT-enabled healthcare market in India is favorable patient demographics. In addition, the rising adoption of mHealth, electronic health records, web-based services, and telemedicine also presents a host of opportunities for players within the IT-enabled healthcare market. 

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/it-enabled-healthcare-industry-htm

Last month, the Central Government of India put into practice several IT-based healthcare initiatives. These include an IT-enabled tool to help tobacco users quit their addiction, an audio-based mobile service that delivers weekly voice messages on pre- and post-natal healthcare, a helpline for patients suffering from tuberculosis, an IT-enabled out-patient department registry block at the All India Institutes of Medical Sciences (AIIMS), and a mobile app to train accredited social health activists. 

Aptamers Market - Rise in Scientific Research Activities to Boost the Growth Faster!!

The growing use of aptamers in drug discovery, pharmaceutical studies, as well as disease treatment will help drive the global aptamers market through the current decade, says Transparency Market Research in a recent study. The report is titled ‘Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.’ According to the report, the global aptamers market was valued at US$93.0 million in 2012, and it is expected that the market will reach a valuation of US$4,333.0 million by 2019. This translates to a remarkable CAGR of 73.1% between 2013 and 2019.

However, the report also warns that the growth in the global aptamers market will be restrained to

some extent ethical issues associated with aptamers derived from animals. This drawback will be further compounded by strict regulatory mandates designed around aptamers. However, these drawbacks can be overcome by companies in the global aptamers market by modifying aptamers chemistry. For instance, animal-derived aptamers can be replaced by aptamers obtained via the in-vitro process. 

For the purpose of this study, the global aptamers market is segmented on the basis of types, applications, and geography. The types of aptamers studied in the report include peptide and nucleic acid aptamers. The segment of nucleic acid aptamers was not only the largest as of 2012, but is also expected to be the fastest growing over the report’s forecast period. This is chiefly owing to the widespread use of nucleic acid aptamers in the R&D sector. 

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1335

Likewise, the applications analyzed in the report are: Diagnostics, therapeutics development, research and development, and others. Of these, the diagnostics segment will report consistent growth over the next four years as the demand for aptamers for biomedical diagnostics, biomarker development, and molecular imaging remains steady. However, in terms of pace of growth, therapeutics development applications will outpace all other application segments over the report’s forecast period.

From the geographical standpoint, the aptamers market for the following regions is studied: North America, Asia Pacific, Europe, and Rest of the World. Thanks to several key players in the aptamers market being based in the United States, the North America region was identified as the largest market for aptamers in 2012. This factor also creates an environment that fosters R&D related to aptamers. 

The Europe aptamers market was the second largest from the global standpoint. According to the findings of the report, Europe constituted about 35% of the global aptamers market in 2012. Small scale industries play a key role in keeping the Europe aptamers market firmly on the growth track. The Asia Pacific market is currently brimming with opportunities in diagnostics and pharmaceuticals, enabling the region to post the highest CAGR between 2013 and 2019. 

Browse Full Report: http://www.transparencymarketresearch.com/aptamers-market.html

Protein Engineering Market to Gain from Emphasis on Development of Protein-based Drugs

Protein engineering – the technique of manipulating protein structures to achieve desired properties or the synthesis of proteins to create complex structures – is being widely applied across industry verticals. As a result, the global protein engineering market is expected to grow remarkably over the next few years. A report by Transparency Market Research studies the global protein engineering market to offer growth forecasts as well as a qualitative analysis of the market. The report is titled, ‘Protein Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023.’

The use protein-based drugs, which are preferred for their high specificity, is expected to stimulate

the demand for protein engineering. An increase in the number of amino acids and engineered proteins produced across the world will also fuel the global protein engineering market, the report states. The greater the prevalence of chronic diseases and lifestyle-related disorders, the higher will be the demand for effective therapies. This trend will have a bearing on the trajectory of the global protein engineering market, say TMR analysts. 

By protein type, the market has been segmented into: monoclonal antibodies, insulin, vaccines, erythropoietin, coagulation factors, growth hormones, interferon, and others. Likewise, by technology, the market is segmented into: irrational protein design and rational protein design. From the standpoint of end users, the market is composed of: academic research institutes, pharmaceutical industries, and contract research organizations. 

Care to know more? Visit: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5348

Governments’ support for research and development activities is projected to have a positive impact on the state of protein engineering in both advanced and developing countries. With an emphasis on reducing the burden of diseases on national economies, programs centered on developing efficacious drugs have received a push. The protein engineering market will be a beneficiary of such developments. 

The report states that North America contributes significantly to the global protein engineering market, given the high concentration of academic and commercial research establishments located in the region. Governments of the U.S., Canada, and Brazil have been highly supportive of advancements in protein engineering, creating a favorable regulatory environment for companies in the North American market. Europe follows close on the heels of North America owing to similar growth factors. Asia Pacific is beginning to show much promise as an investment destination for companies in the protein engineering market because of the presence of numerous contract research organizations (CROs) and the sheer number of people suffering from chronic diseases that can be treated with protein-based therapies. This catapults Asia Pacific to the leading position as far as the rate of growth in the protein engineering market is concerned. 

The leading players that have been profiled in the report on the protein engineering market are: Bio-Rad Laboratories, Inc., Novartis AG, GlaxoSmithKline Inc., Thermo Fisher Scientific, Eli Lilly and Company, Genentech, Inc., and others.